78 results
8-K
EX-10.1
BTAX
Biostax Corp.
27 Jul 20
Departure of Directors or Certain Officers
3:07pm
of Immune.
BENEFITS. Executive shall be entitled to employment benefits, as provided by Immune’s policies in effect from time to time. This may include … healthcare, dental, life insurance, and any other benefits offered to employees in Immune’s future benefit policies but at a minimum shall include
8-K
EX-10.1
BTAX
Biostax Corp.
25 Sep 19
Entry into a Material Definitive Agreement
5:05pm
)) and other unaccrued benefits shall terminate, except as may be provided for inARTICLE 4.
ARTICLE 2
TITLE; DUTIES AND OBLIGATIONS; LOCATION
Section … , responsibilities, reporting level, compensation and benefits, as well as the Company’s personnel policies and procedures, may be changed with or without notice
8-K
BTAX
Biostax Corp.
25 Sep 19
Entry into a Material Definitive Agreement
5:05pm
entitled to receive employee benefits afforded under the Company’s standard written benefits package to regular full-time employees of the Company … incurred by Mr. Handley in the performance of his duties as CEO and President. Mr. Handley is also entitled to receive payments and benefits
8-K
EX-10.1
jgu645u
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
EX-99.1
fruvqfpwj0sz6qm bk
20 Jan 15
Immune Therapeutics, Inc. Announces Appointment of New Director and Acceptance of Election by Director
12:00am
10-12G/A
EX-10.13
g3u5dlelgqc46s19bcd
25 Sep 13
Registration of securities (amended)
12:00am